comparemela.com

Latest Breaking News On - Birgit girshick - Page 2 : comparemela.com

Charles River Laboratories International (NYSE:CRL) Stock Rating Lowered by Guggenheim

Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Guggenheim from a “buy” rating to a “neutral” rating in a report issued on Thursday, Briefing.com reports. Other analysts have also issued research reports about the stock. Citigroup boosted their price target on shares of Charles River Laboratories International from […]

UBS Group Increases Charles River Laboratories International (NYSE:CRL) Price Target to $290 00

Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price objective raised by equities researchers at UBS Group from $270.00 to $290.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the medical research company’s stock. UBS Group’s price target would suggest a potential […]

Charles River Laboratories International (NYSE:CRL) Given New $265 00 Price Target at Evercore ISI

Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price target lifted by Evercore ISI from $260.00 to $265.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the medical research company’s stock. Evercore ISI’s target price would indicate a potential upside of 8.54% from […]

Charles River Laboratories International (NYSE:CRL) Posts Quarterly Earnings Results, Beats Estimates By $0 07 EPS

Charles River Laboratories International (NYSE:CRL – Get Free Report) announced its earnings results on Wednesday. The medical research company reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.39 by $0.07, Briefing.com reports. Charles River Laboratories International had a net margin of 11.27% and a return on equity of 18.15%. The […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.